IL6 and gastric cancer: The adipokine IL-6 is able to promote tumour growth and metastasis, while EGCG was able to inhibit IL-6 induced VEGF expression and angiogenesis in both in vitro and in vivo models of gastric cancer by suppressing STAT3 activity [121].